A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression

EMBO Journal

Volumn 17, Issue 17, 1998, Pages 5015-5025

  Utrera, René ^a,b   Collavin, Licio ^a   Lazarević, Dejan ^a   Delia, Domenico ^c   Schneider, Claudio ^a,d  

^a Lab Naz Consorzio I   (Italy)

^b UNIVERSIDAD SIMÓN BOLÍVAR   (Venezuela)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

G2 specific; Microtubule localized protein; p53; p53 induced gene; Val5 fibroblasts

Indexed keywords

PROTEIN P53;

ARTICLE; CELL CYCLE G2 PHASE; CELL TYPE; DNA CONTENT; DNA DAMAGE; FIBROBLAST; FLOW CYTOMETRY; GENE ISOLATION; HYBRIDIZATION; IMMUNOFLUORESCENCE; MICROTUBULE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL COMPARTMENTATION; CELLS, CULTURED; FIBROBLASTS; G2 PHASE; GENE EXPRESSION REGULATION; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 0032167455     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.17.5015     Document Type: Article

References (45)

1. 1 cell-cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl Acad. Sci. USA, 92, 8493-8497.
2. Andreassen, P.R. and Margolis, R.L. (1994) Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J. Cell Biol., 127, 789-802.
3. Bates, S. and Vousden, K.H. (1996) p53 in signalling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6, 12-18.
4. Brancolini, C., Benedetti, M. and Schneider, C. (1995) Microfilament reorganization during apoptosis: the role of gas2, a possible substrate for ICE-like proteases. EMBO J., 14, 101-112.
5. Brown, C.R., Doxsey, S.J., White, E. and Welch, W.J. (1994) Both viral (adenovirus E1B) and cellular (hsp70, p53) components interact with centrosomes. J. Cell. Physiol., 160, 47-60.
6. Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T. and Hannon, G.J. (1995) Radiation-induced cell-cycle arrest compromised by p21 deficiency. Nature, 377, 552-557.
7. Chomczynski, P. (1992) One-hour downward capillary blotting of RNA at neutral pH. Anal. Biochem., 201, 134-139.
8. Chomczynsky, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
9. Cross, S.M, Sanchez, C.A., Morgan, C.A., Schimke, M.K., Ramel, S., Idzerda, R.L., Raskind, W.H. and Keid, B.J. (1995) A p53-dependent mouse spindle checkpoint. Science, 267, 1353-1356.
10. Del Sal, G., Ruaro, E., Utrera, R., Cole, C.N., Levine, A.J. and Schneider, C. (1995) Gas1 induced growth suppression requires a transactivation independent p53 function. Mol. Cell. Biol., 15, 7152-7160.
11. Del Sal, G., Murphy, M., Ruaro, E., Lazarevic, D., Levine, A.J. and Schneider, C. (1996) Cyclin D1 and p21/WAF1 are both involved in p53 growth suppression. Oncogene, 12, 177-185.
12. Delia, D. et al. (1997) Dissociation between cell cycle arrest and apoptosis can occurr in Li-Fraumeni cells heterozygous for p53 gene mutations. Oncogene, 14, 2137-2147.
13. 1 checkpoint control. Cell, 82, 675-684.
14. El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. and Vogelstein, B. (1992) Definition of a consensus binding site for p53. Nature Genet., 1, 45-49.
15. El-Deiry, W.S. et al. (1993) WAF-1, a potential mediator of p53 tumour suppression. Cell, 75, 817-825.
16. Finlay, C.A., Hinds, P.W., Tan, T.H., Eliyahu, D., Oren, M. and Levine, A.J. (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol., 8, 531-539.
17. Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S. and Vande Woude, G.F. (1996) Abnormal centrosome amplification in the absence of p53. Science, 271, 1744-1747.
18. Furnari, B., Rhind, N. and Russell, P. (1997) Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science, 277, 1495-1497.
19. Hansen, R. and Oren, M. (1997) p53-from inductive signal to cellular effect. Curr. Opin. Genet. Dev., 7, 46-51.
20. Harvey, D.M. and Levine, A.J. (1991) p53 alteration is a common event in the spontaneous immortalisation of primary Balb/c murine embryo fibroblasts. Genes Dev., 5, 2375-2385.
21. Hecker, D., Page, G., Lohum, M., Weiland, S. and Scheidtmann, K.H. (1996) Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs. Oncogene, 12, 953-961.
22. Hermeking, H. and Eick, D. (1994) Mediation of c-Myc induced apoptosis by p53. Science, 265, 2091-2093.
23. 2/M progression. Mol. Cell, 1, 3-11.
24. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancer Science, 253, 49-53.
25. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradism. Genes Dev., 10, 1054-1072.
26. Lanni, J.S. and Jacks, T. (1998) Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol., 18, 1055-1064.
27. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
28. Li, Y., Jenkins, C.W., Nichols, M.A. and Xiong, Y. (1994) Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene, 9, 2261-2268.
29. Lin, J., Chen, J., Elenbaas, B. and Levine, A.J. (1994) Several hydrophobic aminoacids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev., 8, 1235-1246.
30. 1 arrest in UV-irradiated human skin fibroblasts. Cancer Res, 57, 3390-3394.
31. Luckow, B. and Schutz, G. (1987) CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res., 15, 5490.
32. Macleod, K.F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B. and Jacks, T. (1995) p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes Dev., 9, 935-944.
33. Martinez, J., Georgoff, I., Martinez, J. and Levine, A.J. (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev., 5, 151-159.
34. Michalovitz, D., Halevy, O. and Oren, M. (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell, 62, 671-680.
35. Michieli, P., Chedid, M., Lin, D., Pierce, J.H., Mercer, W.E. and Givol, D. (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res, 54, 3391-3395.
36. Murphy, M., Hinman, A. and Levine, A.J. (1996) Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev., 10, 2971-2980.
37. Olmsted, J.B. (1991) Non-motor microtubule-associated proteins. Curr. Opin. Cell Biol., 3, 52-58.
38. Ookata, K. et al. (1995) Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics. J. Cell Biol., 128, 849-862.
39. Sabbatini, P., Chiou, S.K., Rao, L. and White, E. (1995) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B-19K protein. Mol. Cell. Biol., 15, 1060-1070.
40. Sambrook, J., Fritsh, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
41. Stewart, N., Hicks, G.G., Paraskevas, F. and Mowat, M. (1995) Evidence for a second cell-cycle block at G2/M by p53. Oncogene, 10, 109-115.
42. Waldman, T., Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature, 381, 713-716.
43. 1 cyclin-dependent kinases. Nature, 376, 88-91.
44. Wu, X. and Levine, A.J. (1994) p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl Acad. Sci. USA, 91, 3602-3606.
45. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704.